Found 0 matching trials
A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma N/A An open-label, single-arm, multicenter, prospective clinical study of Hanli...
Show More Location
Department of Oncology, The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma PHASE2 The purpose of this study is to improve efficacy of treatment for patients ...
Show More Location
Mannheimer Onkologie Praxis
Learn More & Join Trial
Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer PHASE2 Patients with pretreated, Her2-negative, advanced breast cancer will receiv...
Show More Location
Hämatologie und Onkologie/Interne E, LKH Feldkirch
Learn More & Join Trial
BR Combined With OR in Treatment-naïve Marginal Zone Lymphoma PHASE2 This is a multi-center, prospective study. The main purpose is to evaluate ...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients PHASE1 This study is testing a combination of chemo-immuno therapy called RBM. RBM...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma PHASE3 This is a randomized, open label, multicenter phase III trial comparing the...
Show More Location
Moores UC San Diego Cancer Center
Learn More & Join Trial
Bendamustine Plus Rituximab Versus CHOP Plus Rituximab PHASE3 The study addresses the question if the first line therapy of low malignant...
Show More Location
StiL Head Office; Justus-Liebig-University
Learn More & Join Trial
A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma PHASE1 This is a Phase 1, open-label, multicenter study evaluating the safety, pha...
Show More Learn More & Join Trial
Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia PHASE3 The primary objective of this study is to evaluate the progression-free sur...
Show More Location
St. Jude Heritage Healthcare Virginia K. Crosson Cancer Center
Learn More & Join Trial
Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma PHASE1 This study will be conducted as a Phase Ib, open-label, non-randomized, sin...
Show More Location
University of California, Davis
Learn More & Join Trial